Llwytho...
New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice
Varenicline, a partial agonist for α4β2* nicotinic acetylcholine receptors (nAChRs) and a full agonist for α3β4 and α7 nAChRs, is approved for smoking cessation treatment. Although, partial agonism at α4β2* nAChRs is believed to be the mechanism underlying the effects of varenicline on nicotine rewa...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Neuropharmacology |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6054891/ https://ncbi.nlm.nih.gov/pubmed/29860196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2018.05.025 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|